Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Anti-Alpha-Amino-3-Hydroxy-5-Methyl-4-Isoxazolepropionic Acid Receptor Encephalitis: A Review.

Frontiers in immunology - 1 Jan 2021

Zhang Tian-Yi, Cai Meng-Ting, Zheng Yang, Lai Qi-Lun, Shen Chun-Hong, Qiao Song, Zhang Yin-Xi

Abstract excerpt

Anti-alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPAR) encephalitis, a rare subtype of autoimmune encephalitis, was first reported by Lai et al. The AMPAR antibodies target against extracellular epitopes of the GluA1 or GluA2 subunits of the receptor. AMPARs are expressed throughout the central nervous system, especially in the hippocampus and other limbic regions. Anti-AMPAR encephalitis...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Autoantigens
Share to Autoimmunity
Share to Combined Modality Therapy

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Diagnostic Imaging

Share to Disease Management

Share to Encephalitis

Share to Receptors, Glutamate

Share to Symptom Assessment

Source

Open in PubMed Open full text

Identifiers

PMID: 34093540
DOI: 10.3389/fimmu.2021.652820
PMCID: PMC8175895

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Anti-Alpha-Amino-3-Hydroxy-5-Methyl-4-Isoxazolepropionic Acid Receptor Encephalitis: A Review.PMID 34093540Read ↗

Clinical and neuroradiological findings in patients with Anti-alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor encephalitis: Associations with outcomesSemantic proximity Read ↗

Management of anti-NMDAr encephalitis in the Intensive Care Unit: a case reportSemantic proximity Read ↗

Anti-NMDA Receptor Encephalitis Following SARS-CoV-2 Infection: A Systematic Review and Pooled Case SeriesSemantic proximity Read ↗

A Case Series of Anti-Metabotropic Glutamate Receptor 2 Antibody-Related Diseases with Distinct Neurological InvolvementSemantic proximity Read ↗

Differences and diversity of autoimmune-mediated encephalitis in 77 cases from a single tertiary care centerSemantic proximity Read ↗

NMDA and AMPA Receptor Autoantibodies in Brain Disorders: From Molecular Mechanisms to Clinical FeaturesSemantic proximity Read ↗

Clinical and imaging analysis to evaluate the response of patients with anti-DPPX encephalitis to immunotherapySemantic proximity Read ↗

Identification and Characterization of GABAA Receptor Autoantibodies in Autoimmune EncephalitisSemantic proximity Read ↗

Clinical analysis of MOG antibody-associated disease overlapped with anti-NMDA receptor encephalitis: a long-term retrospective studySemantic proximity Read ↗

Neuronal central nervous system syndromes probably mediated by autoantibodiesSemantic proximity Read ↗

Clinical characteristics and treatment of patients with overlapping MOG and anti-NMDAR encephalitisSemantic proximity Read ↗

NMDA-receptor-Fc-fusion constructs neutralize anti-NMDA receptor antibodiesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.